Community Health Systems, Inc.
NYSE:CYHMedical - Care Facilities
+$0.05 today
- Market cap
- $262.31M
- Beta
- 1.86
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.66
Volume 2.88M
Average 1.61M
CYH Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Community Health Systems, Inc.NYSE: CYH
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 80M | -5.9% |
| FY2022 | 2022-12-31 | 85M | -21.3% |
| FY2021 | 2021-12-31 | 108M | — |
Research & Development vs competitors
How CYH compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for CYH, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $219.98M USD | +42.7% | +34.6% | 249.3% | |
| LTM Mar 2026 | $110.07M USD | -12.0% | +22.1% | — | |
| LTM Apr 2026 | $89.5M USD | +0.1% | +5.8% | 10.4% | |
| LTM Mar 2026 | $22.9M USD | -6.9% | -8.9% | 3.2% | |
| LTM Mar 2026 | $11.72M USD | +17.1% | -23.9% | 4.9% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
AUNAAuna S.A. | LTM Mar 2026 | PEN 0 PEN | — | — | 0.0% |
| Peer median (excluding CYH) | — | +0.1% | +5.8% | 1.6% | |
Competitors are the stored peer set for CYH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.37B | 12.21B | 12.49B | 12.63B | 12.49B |
| Cost of Revenue | 7.28B | 7.31B | 7.41B | 7.36B | 11.4B |
| Gross Profit | 5.08B | 4.91B | 5.08B | 5.27B | 1.08B |
| Gross Margin | 41.1% | 40.2% | 40.7% | 41.7% | 8.7% |
| Research & Development | 108M | 85M | 80M | 0 | 0 |
| Selling, General & Admin | 308M | 317M | 319M | 299M | 0 |
| Operating Expenses | 3.68B | 4.09B | 4.13B | 4.73B | 11B |
| Depreciation & Amortization | 432M | 449M | 425M | 406M | 426M |
| EBITDA | 1.71B | 1.17B | 1.3B | 1.25B | 2.02B |
| EBITDA Margin | 13.8% | 9.6% | 10.4% | 9.9% | 16.2% |
| Operating Income | 1.4B | 821M | 957M | 542M | (9.92B) |
| Operating Margin | 11.3% | 6.7% | 7.7% | 4.3% | -79.4% |
| Interest Income | 0 | 0 | 2M | 3M | 0 |
| Interest Expense | 885M | 858M | 832M | 863M | 870M |
| Other Income / Expenses | (903M) | (472M) | (750M) | (825M) | 10.64B |
| Income Before Tax | 499M | 349M | 207M | (283M) | 724M |
| Pre-Tax Margin | 4.0% | 2.9% | 1.7% | -2.2% | 5.8% |
| Income Tax Expense | 131M | 170M | 191M | 79M | 48M |
| Net Income | 230M | 46M | (133M) | (516M) | 509M |
| Net Margin | 1.9% | 0.4% | -1.1% | -4.1% | 4.1% |
| EPS (Basic) | 1.82 | 0.36 | (1.02) | (3.90) | 3.80 |
| EPS (Diluted) | 1.76 | 0.35 | (1.02) | (3.90) | 3.77 |
| Weighted Avg Shares | 126.75M | 128.81M | 130.39M | 132.1M | 134M |
| Weighted Avg Shares (Diluted) | 130.6M | 130.06M | 130.45M | 132.1M | 135M |
Community Health Systems, Inc.
NYSE:CYH
Intrinsic Alpha fair value
Locked
Current Price
$1.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.